Merck (MRK)
$89.54
0.16 (0.18%)
MRK Stock Quote Delayed 30 Minutes
Dow Jones Today: Stocks Are Already Acting Like a Recession Is Here
Stocks stumbled again Tuesday as the ongoing decline in the oil pitch, coupled with fears a new coronavirus stimulus package will prove inadequate in bolstering the economy, served confirmation that a recession is setting in.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$91.43
Market Cap
226.10B
PE Ratio
13.29
EPS
6.7363
Volume (Avg. Vol.)
13.20M
Day's Range
$88.86 - $91.37
52-Week Range
$81.04 - $132.70
Dividend & Yield
$3.12 (3.48%)
MRK Stock Predictions, Articles, and Merck News
Merck’s Spinoff Promises Higher Dividends and Big Upside
Merck's proposed spinoff of women's health and other prescription drug businesses looks to boost growth and upside for MRK stock.
Merck’s Spinoff Plans Place a Big Bet on Cancer-Fighting Keytruda
Merck stock fell on news it will spin off slow-growth areas to focus on Keytruda, its anti-cancer immunotherapy blockbuster.
Merck Earnings: MRK Stock Moves 4% Lower on Spin-Off News
Merck (MRK) earnings for the healthcare company's fourth quarter of 2019 have MRK stock down Wednesday on major spin-off news.
A Recent FDA Approval Will Be Huge in Moving Amarin Stock
FDA approval of Vascepa in use for cardiovascular events just widened Amarin’s revenue potential. Amarin stock should have a banner 2020.
Dow Jones Today: Data Does It Again
Some solid consumer sentiment and spending reports boosted stocks to close the week, although gains were modest.
3 Big Stock Charts for Thursday: Merck, Anheuser-Busch InBev, and PPG Industries
Thursday's 3 big stock charts highlight 3 recent movers that could rally if broad market optimism continues.
Dow Jones Today: Struggling at the Highs
Some of today's malaise can be attributed to Alphabet (NASDAQ:GOOGL,GOOG), which declined following a disappointing earnings report issued yesterday after the market closed. The internet search giant reported earnings of $10.12 a share on revenue of $40.50 billion while analysts expected earnings of $12.42 on revenue of $40.32 billion.
Stock Market Today: Earnings, Fed Drive New Highs
The S&P 500 hit another new all-time high on Tuesday. Here's what happened in the stock market today to get it there.
Dow Jones Today: Fed Obliges, Stocks Don’t
A divided Federal Reserve is a new issue for investors to consider. Read more about what happened in the Dow Jones today.
Bristol-Myers Squibb Stock Has Upside — But Mind the Risks
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
